June 26 (Reuters) - British consumer healthcare company Haleon said on Wednesday it would sell its nicotine replacement therapy business outside the United States to a unit of India's Dr. Reddy's for 500 million pounds ($632.55 million).

This divestment will allow Haleon to exit the NRT category outside of the US and will reduce complexity across the business allowing increased focus on its strategic growth areas, Haleon said. ($1 = 0.7905 pounds) (Reporting by Yadarisa Shabong in Bengaluru, Editing by Saumyadeb Chakrabarty)